Effect of recombinant interleukin-1β on murine CD14 gene expression in vivo

Shock

Volumn 9, Issue 3, 1998, Pages 157-163

  Fearns, Colleen ^a   Ulevitch, Richard J ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTISERUM; CD14 ANTIGEN; INTERLEUKIN 1; LIPOPOLYSACCHARIDE; MESSENGER RNA; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; DOSE RESPONSE; DRUG EFFECT; EPITHELIUM; FEMALE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE; MOUSE STRAIN;

ANIMALS; ANTIBODIES; ANTIGENS, CD14; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIUM; FEMALE; GENE EXPRESSION REGULATION; IMMUNE SERA; INTERLEUKIN-1; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED STRAINS; RECOMBINANT PROTEINS; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032015110     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199803000-00001     Document Type: Article

References (16)

1. Lee JD, Kato K, Tobias PS, Kirkland TN, Ulevitch RJ: Transfection of CD14 into 70Z/3 cells dramatically enhances the sensitivity to complexes of lipopolysaccharide (LPS) and LPS binding protein. J Exp Med 175: 1697-1705, 1992.
2. Ferrero E, Jiao D, Tsuberi BZ, et al: Transgenic mice expressing human CD14 are hypersensitive to lipopolysaccharide. Proc Natl Acad Sci USA 90:2380-2384, 1993.
3. Haziot A, Ferrero E, Kontgen F, et al: Resistance to endotoxin shock and reduced dissemination of Gram-negative bacteria in CD14-deficient mice. Immunity 4:407-414, 1996.
4. Han J, Lee J-D, Tobias PS, Ulevitch RJ: Endotoxin induces rapid protein tyrosine phosphorylation in 70Z/3 cells expressing CD14. J Biol Chem 268:25009-25014, 1993.
5. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC: CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431-1433, 1990.
6. 23) inhibits soluble CD14-mediated lipopolysaccharide-induced endothelial adherence for human neutrophils. Shock 1:81-86, 1994.
7. Leturcq DJ, Moriarty AM, Talbott G, Winn RK, Martin TR, Ulevitch RJ: Antibodies against CD14 protect primates from endotoxin-induced shock. J Clin Invest 98:1533-1538, 1996.
8. Fearns C, Kravchenko VV, Ulevitch RJ, Loskutoff DJ: Murine CD14 gene expression in vivo: Extramyeloid synthesis and regulation by lipopolysaccharide. J Exp Med 181:857-866, 1995.
9. Fearns C, Loskutoff DJ: Role of tumor necrosis factor-α in induction of murine CD14 gene expression by lipopolysaccharide. Infect Immun 65: 4822-4831, 1997.
10. Dinarello CA: Biologic basis for interleukin-1 in disease. Blood 87:2095-2147, 1996.
11. Pruitt JH, Copeland EMI, Moldawer LL: Interleukin-1 and interleukin-1 antagonism in sepsis, systemic inflammatory response syndrome, and septic shock. Shock 3:235-251, 1995.
12. Landmann R, Ludwig C, Obrist R, Obrecht JP: Effect of cytokines and lipopolysaccharide on CD14 antigen expression in human monocytes and macrophages. J Cell Biochem 47:317-329, 1991.
13. Lauener RP, Goyert SM, Geha RS, Vercelli D: Interleukin 4 down-regulates the expression of CD14 in normal human monocytes. Eur J Immunol 20:2375-2381, 1990.
14. Dinarello CA: The proinflammatory cytokines interleukin-1 and tumor necrosis factor and treatment of the septic shock syndrome. J Infect Dis 163:1177-1184, 1991.
15. Lorenz H-M, Antoni C, Valerius T, et al: In vivo blockade of TNF-α by intravenous infusion of a chimeric monoclonal TNF-α antibody with rheumatoid arthritis. J Immunol 156:1546-1653, 1996.
16. Fong Y, Tracey KJ, Moldawer LL, et al: Antibodies to cachetin/tumor necrosis factor reduce interleukin 1β and interleukin 6 appearance during lethal bacteremia. J Exp Med 170:1627-1633, 1989.